LON:CIZ Cizzle Biotechnology (CIZ) Share Price, News & Analysis GBX 2.40 +0.50 (+26.32%) As of 05/30/2025 12:36 PM Eastern Add Share Share Stock Analysis Stock AnalysisChartDividendHoldingsBuy This Stock About Cizzle Biotechnology (LON:CIZ) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Cizzle Biotechnology alerts:Sign Up Key Stats Today's Range 1.81▼ 2.5050-Day Range 1.40▼ 2.4052-Week Range 1.30▼ 2.69Volume14.06 million shsAverage Volume1.16 million shsMarket Capitalization£9.46 millionAssets Under Management£48.98 millionDividend Yield47.08%Net Expense Ratio0.46%Aggregate RatingN/A ETF OverviewCizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.Read More… Cizzle Biotechnology ExpensesTypeCIZLarge Cap ETFsEquity ETFsLON ETFsAll ETFsManagement Fee0.40%0.59%0.57%0.45%0.53%Other Expenses0.25%0.30%0.48%0.25%0.52%Total Expense0.66%0.65%0.72%0.54%0.71%Fee Waiver-0.20%-0.24%-0.49%-0.20%-0.54%Net Expense0.46%0.62%0.63%0.47%0.60% Receive CIZ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cizzle Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Email Address CIZ ETF News HeadlinesCizzle Bio Expands Global Reach with Cayman Islands Launch of Biomarker Blood Tests for Lung and Gastric CancersMay 30 at 12:47 AM | morningstar.comTRADING UPDATES: GetsBusy backs sales outlook; Cizzle raises fundsMay 20, 2025 | lse.co.ukDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profitable miners selling at deep discounts. I call this price gap the Golden Anomaly — and I’ve put together a full report on my top four picks. June 1, 2025 | Golden Portfolio (Ad)Cizzle Brands CEO talks tariffs and strategies with health-focused product lineMay 2, 2025 | msn.comCizzle Biotech Share Chat (CIZ)December 14, 2024 | lse.co.ukCizzle partners with Moffitt Cancer Center for early lung cancer detectionSeptember 13, 2024 | msn.comSee More Headlines CIZ ETF - Frequently Asked Questions How have CIZ shares performed this year? Cizzle Biotechnology's stock was trading at GBX 1.59 at the beginning of the year. Since then, CIZ stock has increased by 51.0% and is now trading at GBX 2.40. View the best growth stocks for 2025 here. How were Cizzle Biotechnology's earnings last quarter? Cizzle Biotechnology Holdings Plc (LON:CIZ) posted its quarterly earnings data on Wednesday, April, 30th. The company reported ($0.60) earnings per share (EPS) for the quarter. How do I buy shares of Cizzle Biotechnology? Shares of CIZ stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Cizzle Biotechnology own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cizzle Biotechnology investors own include Progressive (PGR), Qorvo (QRVO), TAL Education Group (TAL), Teekay Tankers (TNK), Waters (WAT), Preferred Apartment Communities (APTS) and Baidu (BIDU). Fund Details IssuerVictory Capital Management Fund NameVictoryShares Developed Enhanced Volatility Wtd ETF Tax ClassificationRegulated Investment Company Stock ExchangeLONCurrent SymbolLON:CIZ Inception Date9/30/2014 Fund ManagerMannik Dhillon, Stephen Hammers Webwww.cizzlebiotechnology.com Phone44-20-3934-6630Fund Focus Asset ClassEquity BenchmarkNasdaq Victory?International 500 Long/Cash Volatility Weighted Index CategorySize and Style FocusLarge Cap Development LevelDeveloped Markets RegionGlobal Ex-U.S. Number of Holdings505 Fund Statistics Assets Under Management$48.98 million Average Daily Volume$9,243.20 Discount/Premium0.17% Administrator, Advisor and Custodian AdministratorVictory Capital Management Inc. AdvisorVictory Capital Management Inc. CustodianCitibank, N.A. DistributorForeside Fund Services, LLC Transfer AgentCitibank, N.A. TrusteeN/A Lead Market MakerRBC Capital Markets Options OptionableN/A Short Interest15,600 shs Miscellaneous Outstanding Shares394,139,773Beta0.38 Creation Unit50,000 Creation Fee$4,500.00 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free Report Top 4 CIZ HoldingsFederated Treasury Obligations FundHolding Weight: 100.00%China Common Rich RenHolding Weight: 0.00%Constellation Software InHolding Weight: 0.00%EVRAZ PLCHolding Weight: 0.00%Full Holdings DetailsCIZ Sector ExposureCIZ Industry Exposure This page (LON:CIZ) was last updated on 6/1/2025 by MarketBeat.com Staff From Our PartnersBig Oil’s big pivotThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredTrump Just Gave the Green Light to Rewrite Social Security?In a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredBanks aren’t ready for this altcoin—are you?I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredThe “supermetal” that could power AIWhile the headlines focus on AI models and chip speed, Elon Musk is investing in the material side of the stor...True Market Insiders | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Buffett Indicator is screaming, “sell stocks, buy gold”A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cizzle Biotechnology Holdings Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Cizzle Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CIZ Stock Free CIZ Stock Alerts